NB-5-MeO-MiPT Oxalate Powder

€ 42,00

NB-5-MeO-MiPT Oxalate Powder is a substituted-tryptamine research material offered by Raw Lab Chems with seller-specified ≥98% purity. It is intended exclusively for controlled chemical, structural, forensic, and analytical laboratory research.

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

SKU: CERT-S-13086 Category:
Description

NB-5-MeO-MiPT Oxalate Powder

Product Overview

NB-5-MeO-MiPT Oxalate Powder is described in the supplied information as a substituted-tryptamine research material structurally related to 5-MeO-MiPT. The source characterizes the material as an N-benzyl or protected derivative within the broader 5-methoxytryptamine research class and positions it for controlled analytical, structural, forensic, and comparative chemical investigation.

Raw Lab Chems presents the material exclusively for laboratory and analytical research. The supplied specification states ≥98% purity for a typical batch. Although the source describes this value as third-party verified, no corresponding Certificate of Analysis or independent laboratory report accompanied the supplied information. The purity value is therefore treated as seller-provided information rather than independently verified analytical evidence.

The supplied material discusses structural features, chromatographic behavior, spectroscopic characterization, biochemical binding assays, and analytical detection. These subjects establish laboratory research context only. They do not establish suitability for human or veterinary exposure or any therapeutic, behavioral, recreational, or other consumptive application.

Chemical Identity & Classification

The supplied chemical name is N-benzyl-5-methoxy-N-methyl-N-isopropyltryptamine oxalate, followed by the qualification “or protected analog as per salt form.”

The source additionally provides CAS 1437836-39-3, molecular formula C22H28N2O5, and an approximate molecular weight of 408.48 g/mol. The molecular formula is specifically identified in the source as representing the oxalate salt. NB-5-MeO-MiPT Oxalate Powder

An identity ambiguity remains in the supplied information. The introduction describes the compound as an “N-benzyl or protected derivative,” while the chemical-name field specifically identifies an N-benzyl structure but then adds the broader qualification “or protected analog as per salt form.” Those descriptions are not silently treated as interchangeable. Batch-specific identity documentation would be required to establish the exact structure and chemical form represented by the supplied material.

The compound is described broadly as belonging to the 5-methoxytryptamine class of substituted tryptamines and as being structurally related to 5-MeO-MiPT.

Researchers may consult PubChem for public chemical-reference information while confirming that any selected database record corresponds to the exact derivative, salt state, and structure documented for the research sample.

Chemical & Physical Characteristics

The supplied material is described as a fine crystalline powder intended for controlled laboratory handling, weighing, and analytical characterization.

No verified color, crystal system, polymorphic form, particle-size distribution, melting point, density, hygroscopicity, quantitative solubility, or other detailed physical measurements were provided. These characteristics are therefore not inferred from 5-MeO-MiPT or from other substituted tryptamine materials. NB-5-MeO-MiPT Oxalate Powder

The supplied molecular formula is C22H28N2O5, identified as corresponding to the oxalate salt, while the supplied molecular weight is approximately 408.48 g/mol. Because the source itself contains qualified wording concerning the exact derivative or protected form, these specifications should remain connected to the supplied identity description rather than being generalized to other related structures.

The source recommends storage in a cool, dry location protected from light and identifies 2–8°C as the preferred range for optimal long-term stability. No supporting stability study, degradation profile, or validated shelf-life dataset accompanied the supplied information. This recommendation is therefore retained as seller-provided storage guidance rather than independently validated stability data.

Purity & Analytical Verification

The supplied specification for NB-5-MeO-MiPT Oxalate Powder states ≥98% purity for a typical batch.

The source characterizes this purity level as third-party verified and states that Certificates of Analysis are available upon request. HPLC, LC-MS, and NMR spectroscopy are additionally identified as analytical techniques relevant to characterization of the material.

No batch-specific Certificate of Analysis, HPLC chromatogram, LC-MS dataset, NMR spectrum, or independent laboratory report accompanied the supplied information. Consequently, the stated purity and third-party verification claims are treated as seller-supplied information rather than independently established analytical results. NB-5-MeO-MiPT Oxalate Powder

HPLC, LC-MS, NMR, and related instrumental techniques may support chemical identity, purity, impurity-profile, and structural investigations when appropriately validated for the intended analytical objective.

For this material, analytical documentation should also establish whether the sample corresponds precisely to the N-benzyl oxalate identity described in the chemical-name field or to another protected analogue referenced by the source. Analytical results should not automatically be transferred between chemically distinct derivatives.

Quality Control & Batch Integrity

Reliable analytical research requires documentation connecting observations to the exact material examined. Useful records can include chemical identity, derivative designation, salt or counterion information, supplier, lot or batch identifier, receipt date, storage history, analytical documentation, and chain-of-custody information where appropriate.

The supplied source describes batch-specific tracking, full documentation for traceability, independent laboratory verification of identity and purity, third-party Certificate of Analysis availability, and production under ISO-compliant conditions. NB-5-MeO-MiPT Oxalate Powder

No supporting ISO certification, quality-system documentation, Certificate of Analysis, batch record, independent laboratory report, or other underlying quality documentation was supplied. These statements therefore remain source-provided quality claims rather than independently established certifications or guarantees.

This distinction is particularly relevant because the supplied identity information contains qualified terminology concerning an N-benzyl or protected derivative. Researchers requiring exact structural confirmation should rely on documentation applicable to the specific batch rather than assuming identity from the product name alone. NB-5-MeO-MiPT Oxalate Powder

No additional third-party certification, manufacturing-standard, or batch-to-batch reproducibility guarantee is made without supporting documentation.

Safety, Handling & Laboratory Precautions

The material should be handled exclusively by appropriately trained personnel in a controlled laboratory environment. Suitable personal protective equipment, containment, ventilation, access restrictions, and waste-management procedures should be established through institutional risk assessment and applicable safety documentation.

The supplied source places the material within substituted-tryptamine and serotonergic-receptor research contexts. Such experimental classification does not establish safety or suitability for human or veterinary exposure.

Researchers should consult an applicable Safety Data Sheet for the exact chemical identity and salt form when establishing procedures concerning accidental exposure, spills, contamination control, environmental release, waste collection, and disposal.

The material should remain secured against unauthorized access and separated from food, beverages, children, pets, and non-research environments. Laboratory procedures should also minimize unintended contamination of analytical equipment, reference samples, work surfaces, and waste streams.

Packaging, Labeling & Storage

The supplied source states that research materials are securely packaged with appropriate labeling for chemical research materials. No packaging specification, container-closure validation, transportation study, or supporting technical documentation was provided to independently establish these characteristics.

The supplied storage recommendation specifies a cool, dry environment protected from light, with 2–8°C identified as the preferred range for long-term stability. This recommendation is retained as source-provided guidance rather than represented as independently validated Raw Lab Chems stability data. NB-5-MeO-MiPT Oxalate Powder

Researchers should follow documentation applicable to the specific batch, relevant SDS guidance, and institutional chemical-storage requirements.

Laboratory labeling should preserve the complete compound designation and oxalate identification where applicable. Given the unresolved identity wording in the source, batch documentation should also specify the exact derivative represented by the material. Lot information and storage history should be maintained where available.

Intended Research Use & Market Positioning

NB-5-MeO-MiPT is positioned for controlled laboratory investigation involving chemical characterization, analytical reference work, chromatographic behavior, structural comparison, forensic analysis, impurity profiling, and analytical method development.

The supplied source specifically identifies HPLC, LC-MS, and NMR spectroscopy as relevant analytical techniques. It also describes detection in complex matrices, structure-activity relationship research, biochemical binding assays, pharmaceutical impurity profiling, and academic investigation of substituted tryptamine analogues as research contexts.

References to serotonergic receptor interactions describe an experimental research subject rather than a therapeutic, physiological, behavioral, or recreational effect. NB-5-MeO-MiPT Oxalate Powder

Researchers examining another related catalog material can separately review Raw Lab Chems NB-5-MeO-DALT Oxalate Powder. For comparative analytical research involving a distinct tryptamine-class material, Raw Lab Chems also lists DPT Powder. These materials represent distinct chemical identities and should not be treated as analytically interchangeable.

The Raw Lab Chems NB-5-MeO-MiPT Oxalate Powder research listing provides the catalog reference for the material described here.

No medical, therapeutic, diagnostic, veterinary, recreational, psychoactive, behavioral, or consumptive application is represented by this description.

Ordering, Availability & Fulfillment

Institutional procurement should begin with confirmation of the exact chemical identity, derivative designation, salt form, analytical documentation, institutional authorization, and jurisdiction-specific requirements applicable to the proposed research.

The supplied source describes worldwide shipping to qualified research institutions, secure packaging, chemical-research labeling, and shipment tracking. These logistics statements are not independently verified here, and no current fulfillment documentation was supplied.

No claims are therefore made concerning current inventory, package configurations, dispatch schedules, delivery times, shipping destinations, courier services, tracking availability, customs processing, geographic availability, or payment methods.

Researchers and institutions remain responsible for determining whether acquisition, possession, import, export, transfer, storage, and investigation of this material are permitted and appropriately authorized within their jurisdiction and institutional framework.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. NB-5-MeO-MiPT Oxalate Powder

NB-5-MeO-MiPT is presented as an experimental laboratory research material. Regulatory treatment may differ according to jurisdiction, exact chemical identity, derivative or salt form, intended research activity, institutional policy, and applicable chemical-control, analogue, forensic, medicines, or research frameworks.

Researchers and institutions are responsible for determining and complying with applicable requirements governing acquisition, possession, licensing, import, export, transfer, storage, security, research, environmental handling, and disposal.

A research-use designation does not establish universal legality, medical approval, or exemption from controlled-substance, analogue, medicines, institutional, or other applicable requirements.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “NB-5-MeO-MiPT Oxalate Powder”
Shipping & Delivery